Stacey Jennifer Evans has filed 6 insider transactions across 3 companies since February 2023.
Most recent transaction: a grant/award of 39349 shares of NEOGEN CORP ($NEOG) on May 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | NEOGEN CORP | $NEOG | Stacey Jennifer Evans | Chief Legal Officer | A | Common Stock | 39349 | $9.53 | 39,349.0000 | 217,525,981 | 9999.99% | 0.02% |
| May 1, 2026 | NEOGEN CORP | $NEOG | Stacey Jennifer Evans | Chief Legal Officer | A | Common Stock (Right to Buy) | 89520 | $0.00 | 89,520.0000 | 217,525,981 | 9999.99% | 0.04% |
| June 12, 2025 | Context Therapeutics Inc. | $CNTX | Stacey Jennifer Evans | Director | A | Stock Option (right to buy) | 123500 | $0.00 | 123,500.0000 | 58,416,141 | 9999.99% | 0.21% |
| June 13, 2024 | Context Therapeutics Inc. | $CNTX | Stacey Jennifer Evans | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 15,966,053 | 9999.99% | 0.16% |
| May 31, 2023 | Context Therapeutics Inc. | $CNTX | Stacey Jennifer Evans | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Galera Therapeutics, Inc. | $GRTX | Stacey Jennifer Evans | See Remarks | A | Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 0 | 9999.99% | 0.00% |